Dalmia Cement to sell 42% stake in associate firm to Sarvapriya Healthcare for Rs 800 crore
The decision is in line with the company's "strategy to exit non-core business", and was pursuant to the approval given by the board of directors of Dalmia Bharat, the parent entity.